Disposition of quercetin in man after single oral and intravenous doses
- PMID: 1233267
- DOI: 10.1007/BF00614022
Disposition of quercetin in man after single oral and intravenous doses
Abstract
The pharmacokinetics of quercetin, a flavonoid, have been studied in 6 volunteers after single intravenous (100 mg) and oral (4 g) doses. The data after iv administration were analyzed according to a two compartment open model with half lives of 8.8 +/- 1.2 min for the alpha phase and 2.4 +/- 0.2 h for the beta phase (predominant half life), respectively. Protein binding was greater than 98%. The apparent volume of distribution was small at 0.34 +/- 0.03 1/kg. Of the intravenous dose 7.4 +/- 1.2% was excreted in urine as a conjugated metabolite, and 0.65 +/- 0.1% was excreted unchanged. After oral administration no measurable plasma concentrations could be detected, nor was any quercetin found in urine, either unchanged or in a metabolized form. These results exclude absorption of more than 1% of unchanged drug. Recovery in faeces after the oral dose was 53 +/- 5%, which suggests extensive degradation by microorganisms in the gut. The data obtained show that oral administration of flavonoids may be of questionable value.
Similar articles
-
The physiological disposition of etilefrine in man.Eur J Clin Pharmacol. 1975 Dec 19;9(2-3):179-87. doi: 10.1007/BF00614015. Eur J Clin Pharmacol. 1975. PMID: 9300
-
Pharmacokinetics and bioavailability of the flavonol quercetin in humans.Int J Clin Pharmacol Ther. 1999 May;37(5):219-33. Int J Clin Pharmacol Ther. 1999. PMID: 10363620 Review.
-
Carbon dioxide is the major metabolite of quercetin in humans.J Nutr. 2001 Oct;131(10):2648-52. doi: 10.1093/jn/131.10.2648. J Nutr. 2001. PMID: 11584085 Clinical Trial.
-
Disposition of the flavonoid quercetin in rats after single intravenous and oral doses.Drug Dev Ind Pharm. 2003 Apr;29(4):397-403. doi: 10.1081/ddc-120018375. Drug Dev Ind Pharm. 2003. PMID: 12737533
-
Absolute bioavailability of chlorthalidone in man: a cross-over study after intravenous and oral administration.Eur J Clin Pharmacol. 1979 Feb 19;15(1):35-50. doi: 10.1007/BF00563556. Eur J Clin Pharmacol. 1979. PMID: 421727
Cited by
-
Enhanced anti-proliferative action of busulphan by quercetin on the human leukaemia cell line K562.Br J Cancer. 1989 Mar;59(3):347-8. doi: 10.1038/bjc.1989.68. Br J Cancer. 1989. PMID: 2930697 Free PMC article. No abstract available.
-
Human Sirtuin Regulators: The "Success" Stories.Front Physiol. 2021 Oct 21;12:752117. doi: 10.3389/fphys.2021.752117. eCollection 2021. Front Physiol. 2021. PMID: 34744791 Free PMC article. Review.
-
Concentration-Dependent Pro- and Antitumor Activities of Quercetin in Human Melanoma Spheroids: Comparative Analysis of 2D and 3D Cell Culture Models.Molecules. 2021 Jan 30;26(3):717. doi: 10.3390/molecules26030717. Molecules. 2021. PMID: 33573155 Free PMC article.
-
A comparison of the pharmacokinetics of three different preparations of total flavones of Hippophae rhamnoides in beagle dogs after oral administration.Eur J Drug Metab Pharmacokinet. 2016 Jun;41(3):239-49. doi: 10.1007/s13318-015-0254-9. Epub 2015 Jan 23. Eur J Drug Metab Pharmacokinet. 2016. PMID: 25613316
-
Quercetin Induces Mitochondrial Apoptosis and Downregulates Ganglioside GD3 Expression in Melanoma Cells.Int J Mol Sci. 2024 May 9;25(10):5146. doi: 10.3390/ijms25105146. Int J Mol Sci. 2024. PMID: 38791186 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources